Sun Pharma, Ranbaxy shares rise as court lifts stay on merger

Shares in Sun Pharmaceutical Industries Ltd and Ranbaxy Laboratories Ltd rise after a court

RELATED ARTICLES

lifted a temporary stay it imposed on the acquisition of Ranbaxy by Sun Pharma, paving the way for the completion of the $3.2 billion deal.

The Andhra Pradesh High Court last month ordered an "interim status quo" on the deal, pending a decision on a petition for a probe into alleged insider trading. The petition was filed in late April by two individuals who requested that the court ask the market regulator Sebi and the two main stock exchanges to halt the deal and order a probe.

Shares in Sun Pharma gain as much as 3.88 percent, while Ranbaxy jumps as much as 4.5 percent.

Post new comment

E-mail ID will not be published
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.

EDITORIAL OF THE DAY

  • Strict penalties for coal scam accused is in order

    Throughout history, India has been a resource rich, people poor country.

FC NEWSLETTER

Stay informed on our latest news!

INTERVIEWS

GV Nageswara Rao

MD & CEO, IDBI Federal Life

Timothy Moe

Goldman Sachs

Chander Mohan Sethi

CMD, Reckitt Benckiser India

COLUMNIST

Tushar Gandhi

Could prohibition mean profiteering?

In the mid 1930s, an American journalist asked Bapu if ...

Rajgopal Nidamboor

Drive your faith to awaken your soul

Most of us know about Abraham Maslow’s ‘self-actualised’ individual or ...

Shona Adhikari

The man who perfected the art of stashing

The story of Cornelius Gurlitt, the son of a prominent ...

INTERVIEWS

William D. Green

Chairman & CEO, Accenture